CASL-VAE Learns Latent Variables from Unpaired Data for Disease Analysis

Sai Spandana Chintapalli, Pratik Chaudhari, Christos Davatzikos· July 10, 2026 View original

Summary

Researchers introduce CASL-VAE, a deep contrastive latent variable model that learns structured latent generative factors from unpaired data to quantify population variability. It factorizes variation into common and hierarchical salient factors, enabling improved subtype recovery and paired-sample generation, validated on neuroimaging data for Alzheimer's disease.

In scientific and clinical research, quantifying variability between target and reference populations, such as diseased versus healthy individuals, is a fundamental challenge. Existing methods often struggle with this, especially when paired data is unavailable and target populations exhibit diverse variations. This paper proposes CASL-VAE, a novel deep contrastive latent variable model designed to address these limitations. CASL-VAE excels at learning structured latent generative factors directly from unpaired data. Its key innovation lies in factorizing variation into two distinct types: continuous common latent factors, which are shared across different populations, and hierarchical salient latent factors. These salient factors specifically model target-specific heterogeneity, breaking it down into discrete subtypes and continuous variation within each subtype. Through variational inference, the model optimizes approximate joint likelihood across both reference and target domains using unpaired data, providing a robust framework for generating paired samples and conducting cross-domain analysis. Validation on semi-synthetic neuroimaging data demonstrated CASL-VAE's superior performance in recovering subtypes and generating paired samples compared to existing clustering and generative models. Furthermore, its application to Alzheimer's disease data successfully revealed biologically plausible heterogeneity, highlighting its potential for uncovering complex disease mechanisms.

Why it matters

This research provides a powerful new tool for analyzing complex biological and clinical data, particularly when paired samples are scarce, enabling deeper insights into disease heterogeneity and facilitating the development of personalized treatments.

How to implement this in your domain

  1. 1Apply CASL-VAE to existing unpaired clinical datasets to identify novel disease subtypes or biomarkers.
  2. 2Integrate the model into drug discovery pipelines to better understand patient response variability and stratify patient populations.
  3. 3Utilize CASL-VAE's paired-sample generation capability to augment limited datasets for downstream machine learning tasks.
  4. 4Collaborate with research institutions to validate the model's findings on diverse real-world datasets.
  5. 5Explore the model's applicability in other domains beyond healthcare where structured latent variable learning from unpaired data is beneficial.

Who benefits

HealthcarePharmaceuticalsBiotechnologyMedical Research

Key takeaways

  • CASL-VAE effectively learns structured latent variables from unpaired data.
  • It can identify discrete subtypes and continuous variation within target populations.
  • The model improves subtype recovery and enables principled paired-sample generation.
  • It has shown promise in revealing biologically plausible heterogeneity in diseases like Alzheimer's.

Original post by Sai Spandana Chintapalli, Pratik Chaudhari, Christos Davatzikos

"arXiv:2607.08254v1 Announce Type: new Abstract: Quantifying variability in a target population relative to a reference population is central to many scientific and clinical problems (e.g., diseased vs. healthy). Yet, without paired data and in the presence of heterogeneous target…"

View on X

Originally posted by Sai Spandana Chintapalli, Pratik Chaudhari, Christos Davatzikos on X · view source

Want to go deeper?

Turn these trends into skills with Learnijoy's hands-on AI & tech courses.

Explore courses